OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, February 14th CAAH, UOMO, MDFI, CARN, MOBE

Our Stocks to Watch today include China America Holdings, Inc. (CAAH), UOMO Media Inc. (OTCBB:UOMO), MedeFile International, Inc. (OTCBB: MDFI), Carrington Laboratories, Inc. (OTCBB: CARN), Mobility Electronics, Inc. (NASD: MOBE)

CHINA AMERICA HOLDINGS INCORPORATED (OTCBB: CAAH)

"Up 4.71% in morning trading"

Company Profile:

China America Holdings, Inc. (CAAH) is a diversified Global Holdings Company with operations in the U.S. and China. China America Holdings has three operating divisions.

Shanghai Aohong Chemical Co,, based in Shanghai, China, a distributor of assorted liquid coolants which are utilized in a variety of applications, primarily as refrigerants in air conditioning systems for automobiles, residential and commercial air conditioning systems, and a manufacturer of steel non-refillable cylinders. For more information, please visit the Shanghai Aohong website.

Big Tree Toys, Inc, based in Shantou, China, is an authorized agent for thousands of toy manufacturers in China. Big Tree represents over 8,000 toy manufacturers. Our product offerings include in excess of 180,000 varieties of toy products including remote control toys, digital toys, sports toys, play sets, educational toys, dolls, and infant toys. Big Tree Toys simplifies sourcing products from China. For more information, please visit Big Tree Toys USA and Big Tree Toys website.

Sense Technologies, Inc., based in Ft. Lauderdale, FL, is a leading provider of biometric solutions, and micro-sensor identification systems. Sense develops products targeting Homeland Security, and offers solutions that improve and secure many business, military, and personal processes. Sense owns patents and intellectual property for an MEMS based explosives detection technology licensed through a national government laboratory.

CAAH News:

February 13 - China America Holdings, Big Tree Toys Subsidiary, to Exhibit at Toy Fair 08 in New York

Company Continues to Expand Worldwide Exposure for Its Sales and Logistics Services

China America Holdings, Inc. (OTCBB: CAAH), a diversified holding company operating in both the United States and China, announced that its majority owned subsidiary, Big Tree Toys, Inc., will exhibit at Toy Fair ‘08, sponsored by The Toy Industry Association being held at the Jacob Javits Convention Center in New York City from February 17-20, 2008. The company will be showing and demonstrating new toys and entertainment products from multiple toy manufacturers.

Toy Fair 2008 is another important opportunity for the company to showcase its abilities in sourcing and logistics for toy buyers worldwide. Big Tree has recently exhibited at the International Toys and Games Fair held in Hong Kong January 7-10, 2008. The company presented toys and entertainment products from over 500 manufacturers highlighting new release toys for 2008. The company has focused on quality control safety and offers only toys meeting safety compliance standards.

"Big Tree sales agents met with customers and prospective buyers from over 54 countries from around the world at the Hong Kong event and the company expects to generate new sales and revenue over the next few months from both of these important exhibits," stated Dore Perler, CEO of China America Holdings, Inc.

Big Tree Toys, Inc. will also exhibit at Toy Fair 08, sponsored by The Toy Industry Association being held at the Jacob Javits Convention Center in New York City from February 17-20, 2008. The company will be showing and demonstrating new toys and entertainment products from multiple toy manufacturers.

China America Holdings, Inc. acquired a controlling interest in Big Tree Toys, Inc., a Chinese Toy sourcing and exporting company located in Shantou, China. Big Tree Toys specializes in sourcing and logistics in the toy and entertainment related industry in China. The company represents over 100,000 toys and entertainment related products.

UOMO MEDIA INCORPORATED (OTCBB: UOMO)

"Up 7.46% in morning trading"

UOMO Media Inc. (OTCBB:UOMO) is a publicly trading entertainment company that acquires, produces, manages, and monetizes entertainment-based intellectual property globally. The company is focusing on the development of four core business units: UOMO Digital, UOMO Recorded Music, UOMO Talent Management and UOMO Publishing. There is a massive and ongoing demand for music and entertainment. IFPI estimates that globally, the broader music industry was worth US$130 billion in 2006.

UOMO News:

February 14 - UOMO Producer Tricky Stewart Scores Mariah Carey First Single 'Touch My Body'

"Touch My Body" Written and Produced by UOMO Producer Tricky Stewart, Mariah Carey, and The-Dream Hits Radio This Week

Mariah Carey, the most successful female recording artist in history with total album, single and video sales of more than 160 million worldwide, and Island Def Jam Records announced this week the most eagerly anticipated album of the year, E=MC².

The first single "Touch My Body," written and produced by Tricky Stewart, Mariah Carey and The-Dream, blasted worldwide on February 12. The release of her new album is due in stores April 15.

Tricky Stewart and Redzone Entertainment, who have an exclusive international management agreement with UOMO Media (OTCBB: UOMO), are having an exceptional year to date. Winning the Grammy in the Best Rap/Sung category for Rihanna’s "Umbrella" featuring Jay Z, has made these producers some of the most sought after commodities in the industry. By rolling out hits for artists such as Rihanna, Britney Spears, and Celine Dion, Tricky Stewart and Redzone have shown consistency with which they create top selling music.

"We congratulate Tricky and Redzone on the commercial release of another great piece of work and are confident that the single ‘Touch My Body’ will be a chart topping success," commented Mr. Camara Alford, CEO and Chairman of UOMO Media.

MEDEFILE INTERNATIONAL INCORPORATED (OTCBB: MDFI)

"Up 19.05% in morning trading"

Medefile International, Inc. engages in the development and sale of systems for gathering, digitizing, storing, and distributing information for the healthcare field. The company's products include MedeFile, a b2b and b2c subscription service that is designed to create a ?cradle to grave' longitudinal record by retrieving and consolidating copies of their medical records; Digital Health Profile, which provides a summary of the patient's healthcare history that assists healthcare providers in understanding the patient's course of medical treatment; MedeDrive, an external USB drive, which stores a patient's emergency medical information and their MedeFile that can be viewed on a personal computer; and MedeVault designed to serve as an electronic data and document repository. Its product portfolio also comprises Medefile Clinical Information Systems, a b2b professional consulting service; OmniScan, which is designed to enable medical facilities to convert the paper based medical records into a digital format; and SecurMed that serves as an authentication process, which protects against any information being viewed by unauthorized persons. The company was incorporated in 1997 and is based in Cedar Knolls, New Jersey.

MDFI News:

February 14 - Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients

Administering More Than 180,000 Patient Visits Each Year, East Coast's Largest Independent Clinical Lab Services Company Aspires to Empower Patients with Control Over Medical Care

MedeFile International, Inc. (OTCBB: MDFI), a company specializing in portable electronic medical records management solutions, announced that it has signed a collaborative marketing agreement with Hayes Clinical Laboratory, the largest independent clinical laboratory on Florida's East Coast.

With five locations in Southern Florida and a service region that covers primarily Palm Beach, Broward, Okeechobee, St. Lucie and Martin counties, Hayes Labs is a full service medical laboratory performing tests on all body fluids and tissue. Each year, Hayes administers more than 180,000 patient visits, most of which have been referred from its client base comprised of nearly 500 doctors and healthcare specialists.

Chad Fredrich, President of Hayes, noted, "We routinely see patients who are subjected to redundant clinical testing because they are under the care of physicians who are unaware of other medical providers that are also treating the patient for related or unrelated medical conditions and who have ordered similar tests. This unnecessary redundancy is costly to the patient and costly to the healthcare system. Moreover, insurance payers may refuse to approve payment for testing when patients have exceeded 'frequency limitations' allowable for clinical tests, resulting in our having to write off these billings as bad debt. In this case, testing redundancy is costly to our company. By empowering patients with MedeFile, they gain control over effectively managing their own medical records, can carry actual clinical test results with them wherever they go, and can optimize the care they receive from their treating physicians. We are very excited about teaming with MedeFile International to begin offering this novel, cost-saving solution to the thousands of patients who rely on Hayes for clinical testing services."

Hayes Labs will also engage in actively encouraging its network of referring physicians, in addition to other independent clinical laboratories around the country, to offer MedeFile to their respective patient bases.

"MedeFile is on a mission to educate the nation's healthcare community on the fact that centralizing actual medical records with the patient is the key to achieving real, positive change to the U.S. healthcare delivery system. By winning the support of respected medical institutions and providers, such as Hayes Labs, we are succeeding in helping others to realize and appreciate the many important convenience, care-enhancing and cost-saving benefits made possible with the MedeFile solution," stated Milton Hauser, Chairman and CEO of MedeFile.

CARRINGTON LABS INCORPORATED (OTCBB: CARN)

"Up 30.00% in morning trading"

Carrington Laboratories, Inc. operates as a research-based biopharmaceutical, medical device, raw materials, and nutraceutical company. It engages in the development, manufacture, and marketing of naturally-derived complex carbohydrates and other natural product therapeutics for the treatment of major illnesses, the dressing, and management of wounds and nutritional supplements. The company operates in two segments, Medical Services and Consumer Services. The Medical Services segment sells various wound and skin care medical products, and provides manufacturing services to customers in medical products markets. These products are primarily sold through sole source distributors, and marketed to hospitals, nursing homes, alternative care facilities, cancer centers, home healthcare providers, and managed care organizations. The Consumer Services segment sells and licenses consumer products and bulk raw materials in the consumer health and beauty care products markets. This segment also sells finished products, as well as provides product development and manufacturing services to customers in the cosmetic and nutraceutical markets. In addition, Carrington Laboratories, through its subsidiary, DelSite Biotechnologies, Inc., engages in the research, development, and marketing of its proprietary GelSite technology for controlled release and delivery of bioactive pharmaceutical ingredients. The company was founded in 1973 and is headquartered in Irving, Texas.

CARN News:

February 14 - Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration

- Human Trials to Begin Later This Year

- Only Nasal Powder Bird Flu Vaccine Under Development

- Patient-Friendly (No Needles); No Preservatives

- Stable at Room Temperature For 3 Years; No Cold Chain Distribution Required

Carrington Laboratories, Inc. (OTCBB: CARN) announced that its wholly-owned subsidiary DelSite Biotechnologies, Inc. received a shipment of clinical-grade H5N1 (bird flu) antigen from a major pharmaceutical company to commence production, under cGMP requirements, of clinical quantities of DelSite's nasal powder bird flu (H5N1) vaccine. The nasal powder bird flu vaccine is scheduled to begin testing in a Phase I human clinical trial later this year.

The vaccine will utilize DelSite's proprietary GelVac(TM) nasal powder delivery platform, which offers many distinct advantages over traditional vaccine delivery systems: (1) easy, needle-free, self-administration, not requiring healthcare professionals; (2) enhanced protection because administration of vaccine into nasal cavity stimulates both a systemic response and mucosal response; (3) no adverse side effects caused by preservatives; (4) stability at room temperature, which eliminates the need for cold storage or cold chain distribution, thereby opening distribution to Third World countries where refrigeration is often not available; and, (5) a demonstrated shelf life of an influenza vaccine of three years, enabling potential stockpiling in the event of a pandemic.

As a prelude to the Phase I human trials, in January 2008 toxicology studies were successfully completed on a GelVac nasal powder (H5N1) influenza vaccine. The GelVac nasal powder platform has also successfully completed a Phase I safety study in which the delivery device provided a consistent, greater-than-90-percent delivery of the powder to the desired site in the nose.

Carlton E. Turner, PhD, Carrington's president and CEO, stated, "We are focusing our full attention on advancing DelSite's GelVac nasal powder delivery platform for vaccines and therapeutics, and the H5N1 bird flu antigen was selected specifically for this effort. We completed all toxicology studies last year and reported results in January 2008. Receiving the current shipment of the non-egg-based, clinical-grade bird flu antigen for human studies was the next step in our efforts. Our regulatory pathway has been determined with the FDA, and we intend to proceed with clarity of purpose to the Phase I safety and effectiveness human trial with the nasal powder bird flu vaccine later this year."

Dr. Turner added, "The success of Wyeth's Prevnar® pneumococcal vaccine and Merck's Gardasil® vaccine for cervical cancer has created a renewed interest in vaccines. According to a report by the Pharmaceutical Research and Manufacturers of America, more than 50 companies had 146 vaccines in various stages of development in 2007. Of these, 138 were classical liquid vaccines requiring needles, cold storage (2-8 degrees C), cold chain distribution (2-8 degrees C), and adjuvants and/or preservatives. Five were nasal mist vaccines with the same requirements except for needles, one was an influenza dermal patch, and two were powder formulations. Simply put, those requiring needles are not distributor- or user-friendly, and those requiring cold storage are not distributor- and may not be user-friendly."

"A simple, less expensive, easy-to-distribute, user-friendly delivery system would serve to complete the vaccine paradigm shift away from needles and cold storage/distribution as was started by FluMist®, a liquid nasal spray flu vaccine," Dr. Turner added. "Dr. Nayer Khazani, a specialist in internal medicine who also does research and teaches at Stanford University Medical Center, wrote in an article (February 2, 2008) in the San Francisco Chronicle, stating that ' ... as delivery systems move from needles to patches and nasal powders, prevention (and even cure) may come without the sting.' His comments underscore our belief that the GelVac nasal powder platform developed by DelSite will complete this total paradigm shift and, clearly, without a sting."

"GelVac(TM) powder has been shown to work with and stabilize many antigens and protein and peptide therapeutics," continued Turner. "All formulations tested are stable at room temperature, require no needles, no preservatives, no cold storage and can be shipped anywhere free of the restrictive cold chain distribution systems associated with other vaccines. As a nasal powder, it is patient-friendly and does not require administration by a medical professional. No painful injection could mean greater public acceptance and thus public protection on a broader scale against specific diseases."

"At the corporate level, we are analyzing our business models and exploring strategies to move all our business units forward. We have invested more than $54 million in DelSite and have incurred financial losses over recent years. As a company we are dedicated to funding DelSite's initiatives and programs. The fact that a major pharma company has twice provided us, free of cost, a non-egg based H5N1 bird flu antigen produced under the restriction required for human use, indicates that much of the heavy lifting may be behind us."

MOBILITY ELECTRONICS (NASD: MOBE)

"Up 25.70% in morning trading"

Mobility Electronics, Inc. designs, develops, manufactures and/or distributes power products for the mobile electronics industry. The company offers alternate current (AC), direct current (DC), combination AC/DC, and battery-powered universal power adapters that are designed for use with portable computers, as well as various other low power mobile electronic devices, including mobile phones, smartphones, portable digital assistants, digital cameras, camcorders, MP3 players, and portable game consoles. It also provides infrared and Bluetooth foldable keyboard products that enhance the functionality of converged mobile devices by offering users with a portable keyboard solution. In addition, Mobility Electronics markets various mobile device accessories, such as monitor stands, mobile phone accessories, and portable computer stands. The company sells its products through original equipment manufacturers, private-label resellers, distributors, resellers, and retailers, as well as directly to end users through its iGo Web site primarily in North America, Europe, and Asia Pacific. Mobility Electronics, formerly known as Electronics Accessory Specialists International, Inc., was founded in 1995 and is based in Scottsdale, Arizona.

MOBE News:

February 14 - iGo Universal Chargers Available for Purchase for the First Time in the United Kingdom

Mobility Electronics Announces Groundbreaking Partnership with Maplin Electronics

Mobility Electronics, Inc. (NASD: MOBE), the pioneer in portable power solutions for the mobile electronic device user, announced its iGo universal power adaptors and accessories are available for the first time in select Maplin retailers throughout the United Kingdom.

The iGo power adaptors are available in 86 Maplin retail stores, with plans to move the iGo products into a total of 143 retail stores throughout this year. The iGo products also are sold online at www.maplin.co.uk as well as in the company’s catalogues. Now, consumers in the UK won’t have to wait for their iGo products to be shipped, but can buy the product at Maplin and start experiencing the benefits of iGo immediately.

"Maplin Electronics influences the technology purchases of thousands of UK consumers every day," said Jonathan Downer, executive vice president, worldwide sales and distribution of Mobility Electronics. "Consumers buy tech products at Maplin because they know they’re the newest and most innovative products on the market. This partnership will increase our brand awareness in the UK and strengthen our position as the leading provider of mobile power solutions."

Maplin is the third largest consumer electronics retailer in the UK with 143 retail stores. The company plans to open 20 additional stores this year.

"As we continue to grow our business and customer-base, we’re always looking for new, innovative products to add to our extensive product list," said Gareth Pownall, product manager of Maplin. "I expect the iGo power chargers will be popular among our existing customers and drive new customers into our stores."

In addition to iGo juice70 for laptops, Maplin features iGo’s complete portfolio of chargers for low-power devices, as well as tips for the most popular gadgets found in the UK. The featured products include:

1) iGo juice70 – This compact all-in-one adaptor powers and charges your notebook computer from any standard wall, auto or in-flight outlet. Bundled with the iGo dualpower accessory, users can simultaneously charge a notebook computer and another mobile electronic device.

2) iGo everywhere – A combination AC/DC adaptor that allows users to power/charge nearly all low-power mobile electronic devices from any standard wall or auto outlet. Includes a retractable cord and convenient travel case.

3) iGo in-car charger – DC adaptor that allows users to power virtually any gadget from a standard in-vehicle outlet.

4) iGo AC charger – Ultra-portable AC adaptor that allows users to power/charge multiple gadgets from any standard wall power outlet.

5) iGo powerXtender™ – Utilizes two AA batteries to power/charge virtually any gadget, providing extra runtime when away from standard power outlets.

6) iGo power splitter accessory – This accessory is designed to work with select iGo low power adaptors to simultaneously charge two gadgets, such as mobile phones, Bluetooth® headsets, portable gaming devices, and more from a single adaptor.

iGo power adaptors and chargers leverage the company’s patented tip technology, allowing one adaptor to charge multiple devices through interchangeable tips. Users are able to charge hundreds of brands and thousands of models of mobile electronic devices by simply switching the tips. iGo universal notebook adaptors also come with a dualpower accessory, allowing users to charge their notebook plus a low power device, such as a mobile phone or Bluetooth headset, at the same time.

ABOUT OTCPICKS.COM

Disclaimer:

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.